Science Explorer Back to mapMap
Discussion
Researcher · PsiOxus Therapeutics (United Kingdom) · United Kingdom

David Krige

David Krige publishes mostly in Oncology, Molecular Biology and Genetics, on topics such as CAR-T cell therapy research, Virus-based gene therapy research and Cancer Research and Treatments.

OpenAlex
World rank
#1,718,363
of 7,710,434 ranked researchers
Rank in United Kingdom
#129,311
of 367,258
Works
56
Citations
1.6k
Citations per work
27.8
h-index
15
i10-index 18Top 36% in Oncology
David Krige

What does David Krige research?

David Krige's work is mostly in Biochemistry, Genetics and Molecular Biology (39%), Medicine (26%), Immunology and Microbiology (6%).

Life Sciences: 25 works · 44.8% of their workBiochemistry, Genetics and Molecular Biology: 22 works · 38.9% of their workMolecular Biology: 10 works · 17.6% of their workGenetics: 5 works · 8.8% of their workBiotechnology: 5 works · 8.1% of their workCancer Research: 2 works · 4.4% of their workImmunology and Microbiology: 3 works · 5.9% of their workImmunology: 3 works · 5.9% of their workEverything else: 17 works · 29.5% of their workHealth Sciences: 14 works · 25.7% of their workMedicine: 14 works · 25.7% of their workOncology: 14 works · 25.7% of their workTHEIR WORKDavid Krige56works
Life Sciences45%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2238.9%
    2. Immunology and Microbiology35.9%
  2. Everything else1729.5%
    1. Medicine1425.7%
  1. 1Oncology26% of their works
  2. 2Molecular Biology18% of their works
  3. 3Genetics9% of their works
  4. 4Biotechnology8% of their works
  5. 5Immunology6% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe David Krige's research?

The keywords of their largest research topics: Immunotherapy, Tumor Regression, Gene Therapy, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Cancer Therapy and Tumor Microenvironment.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Immunotherapy262 topics
  2. Tumor Regression262 topics
  3. Gene Therapy232 topics
  4. Cancer Immunotherapy222 topics
  5. CAR T Cells151 topic
  6. Chimeric Antigen Receptor151 topic
  7. Cancer Therapy142 topics
  8. Tumor Microenvironment142 topics
  9. AAV121 topic
  10. Viral Vectors121 topic
  11. Bacterial Therapy111 topic
  12. Tumor Targeting111 topic
  13. Fibroblast Activation Protein81 topic
  14. Immunosuppression81 topic
  15. Dendritic Cells71 topic
  16. Immunity71 topic
  17. HDAC Inhibitors61 topic
  18. Histone Deacetylases61 topic
  19. Immune Checkpoint Blockade61 topic
  20. PD-1 and PD-L161 topic
  21. Mitochondria51 topic
  22. Reactive Oxygen Species51 topic

Where does David Krige work?

David Krige's main affiliation in the publication record is PsiOxus Therapeutics (United Kingdom), United Kingdom.

How many publications and citations does David Krige have?

OpenAlex counts 56 works and 1,557 citations for David Krige, an h-index of 15, ranking #1,718,363 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Krige. Posts are plain text and can be reported.